Deniz Çataklı

9PUBLICATIONS
15CO-AUTHORS
Autonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCell metabolism
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 26, 2025
Nebivolol attenuates acute systemic inflammation induced testicular dysfunction by decreasing transendothelial migration via VCAM-1/MMP-9 signaling.

Ercan Bas, Halil Asci, Yalcin Erzurumlu

|May 14, 2024
Potential Hepatoprotective Effects of Irbesartan, an Accessible Angiotensin II Receptor Blocker, Against Cisplatin-Induced Liver Injury in a Rat Model.

Onur Ertunç, Yalçın Erzurumlu, Mehtap Savran

|Jan 23, 2024
Anticancer Effect of Theranekron® on Androgen-Dependent Prostate Cancer Cells.

Yalçın Erzurumlu, Hatice Kübra Doğan, Deniz Çataklı

|Jan 17, 2024
New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling.

Yalcin Erzurumlu, Hatice Kubra Dogan, Deniz Catakli

|Jul 07, 2023
HERPUD1, a Member of the Endoplasmic Reticulum Protein Quality Control Mechanism, may be a Good Target for Suppressing Tumorigenesis in Breast Cancer Cells.

Yalçın Erzurumlu, Yağmur Doğanlar, Hatice Kübra Doğan

|May 02, 2023
Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells.

Yalcin Erzurumlu, Deniz Catakli, Hatice Kubra Dogan

Pageof 2

Frequent Collaborators

9 joint publications

Yalçın Erzurumlu

7 joint publications

Hatice Kubra Dogan

1 joint publications

Esra Aydogdu

1 joint publications

Muhammed Tilahun Muhammed